NEW ISSUE
Everywhere we turn we are confronted by an ongoing debate about the dangers – and advantages – of artificial intelligence. In the last issue, we spoke about evidence, and here, one of our articles looks at artificial intelligence and the role it could play in one aspect of our clinical lives. There is no reason to believe that hard clinical data and artificial intelligence are necessarily opposed… but we still need to be vigilant. The jury is out, and the evidence needs to be collected – what do you think?
#EIJonAir
Join our upcoming live X (Twitter) video chat on Immediate or staged complete revascularisation in patients presenting with acute coronary syndrome by number of diseased vessels: a substudy of the BIOVASC randomised trial with Hala Kakar and Mirvat Alasnag.
Join our upcoming X (twitter) live on April 16th at 6:00 PM (CET - Paris time)
STATE-OF-THE-ART
In State-of-the-Art, the authors summarise the rationale for RDN, review the available evidence, provide recommendations for a safe procedure, and discuss the role of RDN in current guidelines and clinical practice.
ORIGINAL RESEARCH
ORIGINAL RESEARCH
RESEARCH CORRESPONDENCE
DEBATE
STATE-OF-THE-ART
ORIGINAL RESEARCH
ORIGINAL RESEARCH
Since the launch of its new website in February, EuroIntervention has harnessed the power of AI, integrating this cutting-edge technology in the development and improvement of features such as an optimised user interface and a powerful search engine.
Now, EuroIntervention is unveiling its new AI assistant – the first of its kind in the field of academic publishing - designed to accompany readers and enhance their reading experience.
EDITORIAL
DEBATE
ORIGINAL RESEARCH
